Education
About Us
Working with TipRanks
Follow Us
Assertio Therapeutics (ASRT)
:ASRT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 124.96M | $ 152.07M | $ 156.23M | $ 111.01M | $ 106.28M |
| Gross Profit | $ 85.73M | $ 125.05M | $ 137.49M | $ 95.18M | $ 86.40M |
| Operating Income | $ -24.48M | $ -243.54M | $ 57.81M | $ 9.42M | $ -46.92M |
| EBITDA | $ -24.48M | $ -222.45M | $ 72.53M | $ 38.78M | $ -3.20M |
| Net Income | $ -21.48M | $ -331.94M | $ 109.63M | $ -1.28M | $ -28.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 100.05M | $ 73.44M | $ 64.94M | $ 36.81M | $ 20.79M |
| Total Assets | $ 284.73M | $ 286.42M | $ 413.91M | $ 326.55M | $ 303.27M |
| Total Debt | $ 38.81M | $ 40.91M | $ 66.87M | $ 73.49M | $ 84.10M |
| Net Debt | $ -11.78M | $ -32.53M | $ 1.93M | $ 36.68M | $ 63.32M |
| Total Liabilities | $ 163.65M | $ 148.42M | $ 188.19M | $ 224.13M | $ 247.76M |
| Stockholders' Equity | $ 121.08M | $ 138.00M | $ 225.72M | $ 102.41M | $ 55.51M |
| Cash Flow | |||||
| Free Cash Flow | $ 26.41M | $ 48.98M | $ 78.32M | $ 5.47M | $ -65.58M |
| Operating Cash Flow | $ 26.41M | $ 49.60M | $ 78.60M | $ 5.52M | $ -65.57M |
| Investing Cash Flow | $ -48.91M | $ 3.10M | $ -42.67M | $ -18.52M | $ 512.80M |
| Financing Cash Flow | $ -350.00K | $ -44.20M | $ -7.79M | $ 29.03M | $ -468.55M |